Clinical Trial Using Targeted Therapy “Doubled Survival” in Cancer Patients

MesotheliomaHelp has reported countless times on the benefits of using a personalized treatment approach for mesothelioma patients. When the unique genetic makeup of a patient’s cancer is used to drive the therapy, survival and quality of life improve. Now, researchers report in a clinical trial that used tumor markers to determine the appropriate treatment for patients, regardless of cancer type, the treatment “slowed cancer growth and doubled survival.” The IMPACT trial, touted as “the first and largest precision medicine trial to look at survival,” conducted by researchers from The University of Texas MD Anderson Cancer Center, enrolled 3,743 patients from […]

The post Clinical Trial Using Targeted Therapy “Doubled Survival” in Cancer Patients appeared first on MesotheliomaHelp.org.



from Blog – MesotheliomaHelp.org https://ift.tt/2JE8vN2
via IFTTT
Clinical Trial Using Targeted Therapy “Doubled Survival” in Cancer Patients Clinical Trial Using Targeted Therapy “Doubled Survival” in Cancer Patients Reviewed by Unknown on June 11, 2018 Rating: 5

No comments:

Powered by Blogger.